Momenta Pharmaceuticals
MNTA
#2353
Rank
NZ$11.22 B
Marketcap
$94.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Momenta Pharmaceuticals (MNTA)

Revenue in 2020 (TTM): NZ$47.39 Million

According to Momenta Pharmaceuticals's latest financial reports the company's current revenue is NZ$54.06 Million. In 2019 the company made a revenue of NZ$42.91 Million a decrease over the revenue in the year 2018 that were of NZ$0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Momenta Pharmaceuticals from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)NZ$47.39 M10.44%
2019NZ$42.91 M-68.42%
2018NZ$0.13 B-45.57%
2017NZ$0.24 B26.7%
2016NZ$0.19 B22.28%
2015NZ$0.16 B71.58%
2014NZ$93.94 M47.33%
2013NZ$63.76 M-44.52%
2012NZ$0.11 B-77.42%
2011NZ$0.50 B142.41%
2010NZ$0.20 B476.68%
2009NZ$36.4 M38.97%
2008NZ$26.19 M-32.42%
2007NZ$38.76 M31.7%
2006NZ$29.43 M13.06%
2005NZ$26.03 M84.86%
2004NZ$14.08 M